logo
Promising Penny Stocks To Consider In August 2025

Promising Penny Stocks To Consider In August 2025

Yahoo2 days ago
As the U.S. stock market continues its rally, with major indices like the S&P 500 and Nasdaq hitting new highs, investors are exploring diverse opportunities to capitalize on this momentum. Penny stocks, often associated with smaller or newer companies, remain a compelling area for those looking to uncover hidden value and growth potential. Despite being an older term in the investment lexicon, these stocks can offer intriguing opportunities when backed by robust financials and strategic positioning within their industries.
Top 10 Penny Stocks In The United States
Name
Share Price
Market Cap
Financial Health Rating
Waterdrop (WDH)
$1.83
$679.93M
★★★★★★
WM Technology (MAPS)
$1.27
$192.5M
★★★★★★
Talkspace (TALK)
$2.58
$432.07M
★★★★★★
Performance Shipping (PSHG)
$1.90
$22.88M
★★★★★★
Tuniu (TOUR)
$0.9326
$89.67M
★★★★★★
CI&T (CINT)
$4.86
$662.14M
★★★★★☆
BAB (BABB)
$0.9288
$6.57M
★★★★★★
Lifetime Brands (LCUT)
$3.95
$92.44M
★★★★★☆
Resources Connection (RGP)
$4.93
$151.7M
★★★★★★
TETRA Technologies (TTI)
$3.92
$529.12M
★★★★★★
Click here to see the full list of 400 stocks from our US Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Erasca
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Erasca, Inc. is a clinical-stage precision oncology company dedicated to discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers, with a market cap of approximately $442.49 million.
Operations: Erasca, Inc. currently does not report any revenue segments.
Market Cap: $442.49M
Erasca, Inc., a pre-revenue clinical-stage precision oncology company, recently reported a reduced net loss of US$33.88 million for Q2 2025 compared to the previous year. Despite being unprofitable with negative return on equity and no significant revenue streams, the company remains debt-free and has sufficient cash runway for over two years. Recent developments include FDA clearance for an investigational drug targeting KRAS-mutant tumors and filing a US$500 million shelf registration to potentially raise capital through various securities. The stock exhibits high volatility but has not experienced meaningful shareholder dilution recently.
Take a closer look at Erasca's potential here in our financial health report.
Review our growth performance report to gain insights into Erasca's future.
EVgo
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: EVgo, Inc. owns and operates a direct current fast charging network for electric vehicles in the United States, with a market cap of approximately $1.16 billion.
Operations: The company's revenue is derived from its Retail - Gasoline & Auto Dealers segment, totaling $308.37 million.
Market Cap: $1.16B
EVgo, Inc., with a market cap of US$1.16 billion, is expanding its fast charging network for electric vehicles in the U.S., supported by a recent US$225 million credit facility from global banks. Despite being unprofitable and experiencing increased losses over the past five years, EVgo's revenue is projected to grow significantly. The company reported Q2 2025 sales of US$98.03 million, up from US$66.62 million a year ago, though net losses widened to US$13 million. While short-term liabilities are covered by assets, long-term liabilities remain uncovered; insider selling has been significant recently.
Navigate through the intricacies of EVgo with our comprehensive balance sheet health report here.
Gain insights into EVgo's future direction by reviewing our growth report.
Sana Biotechnology
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Sana Biotechnology, Inc. is a biotechnology company that focuses on utilizing engineered cells as medicines in the United States, with a market cap of approximately $791.90 million.
Operations: Sana Biotechnology, Inc. currently does not report any revenue segments.
Market Cap: $791.9M
Sana Biotechnology, Inc., with a market cap of US$791.90 million, remains pre-revenue and unprofitable but has managed to reduce losses over the past five years by 4.5% annually. The company recently reported a net loss of US$93.8 million for Q2 2025, up from US$50.29 million the previous year, and completed a follow-on equity offering raising approximately US$75 million to extend its cash runway beyond five months. Despite high volatility in its share price and short-term assets not covering long-term liabilities, Sana's strategic advancements include promising clinical results for its hypoimmune technology in diabetes treatment studies.
Dive into the specifics of Sana Biotechnology here with our thorough balance sheet health report.
Assess Sana Biotechnology's future earnings estimates with our detailed growth reports.
Next Steps
Get an in-depth perspective on all 400 US Penny Stocks by using our screener here.
Contemplating Other Strategies? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ERAS EVGO and SANA.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Errore nel recupero dei dati
Effettua l'accesso per consultare il tuo portafoglio
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim
AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim

Yahoo

time10 minutes ago

  • Yahoo

AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim

AT&T Inc. (NYSE:T) customers, both present and past, stand to receive up to $7,500 as part of a proposed $177 million settlement. This settlement is in response to two significant data breaches that affected millions of AT&T customers. What Happened: AT&T Inc. has suggested a settlement amounting to $177 million. This sum includes $149 million for the initial class-action lawsuit and an additional $28 million for the second one. The first data breach, revealed in March 2024, impacted 73 million account holders, with hackers obtaining personal information and disseminating it on the dark web. A subsequent breach in July 2024 compromised the call and text records of almost all AT&T customers. According to the report by New York Post, the settlement is yet to receive approval, with a final hearing set for December 3 in the US District Court for the Northern District of Texas. Customers who had their data compromised can apply for compensation before the hearing. They will be notified via an email from Kroll Settlement Administration and must submit a claim form by November 18. Also Read: GameStop to Pay $4.5 Million Over Alleged Privacy Violations Involving Facebook Data Sharing Customers affected by the March 2024 breach can claim up to $5,000, while those impacted by the July breach can claim up to $2,500. Customers who were affected by both breaches could be eligible for up to $7,500. AT&T will require evidence of losses associated with the breaches. Payouts are anticipated to commence by the end of the year, but may be postponed if appeals are lodged after the hearing. Why It Matters: This settlement proposal comes as a significant development for AT&T customers who were affected by the data breaches. The proposed compensation not only acknowledges the inconvenience and potential harm caused by the breaches, but also serves as a reminder of the importance of robust data security measures for companies handling sensitive customer information. The outcome of the final hearing will be closely watched, as it could set a precedent for future data breach settlements. Read Next Wall Street's Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks Delivering High-Dividend Yields UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? AT&T (T): Free Stock Analysis Report This article AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Are Browsers Key To An Agentic AI Future? Opera, Perplexity Think So
Are Browsers Key To An Agentic AI Future? Opera, Perplexity Think So

Forbes

time12 minutes ago

  • Forbes

Are Browsers Key To An Agentic AI Future? Opera, Perplexity Think So

AI-powered conversational search engine Perplexity is in the news for offering to buy Google's Chrome browser for $34.5 billion. But in December of 2024, Perplexity considered buying The Browser Co. And just months ago, Perplexity reportedly offered to buy Brave, the privacy-focused browser, for about $1 billion. Why does Perplexity want a web browser so badly? Possibly because a browser just might be key to our agentic AI future. I recently interviewed Opera senior product leader Henrik Lexow on my TechFirst podcast. Opera, the 30-year-old browser company that pioneered tabbed browsing, pop-up blocking, and ad blockers, has about 300 million active users globally. This year, Opera was the first to bring AI agents right into our browsers in a project called Opera Neon. 'The agentic browser … is that sort of the new operating system?' Lexow asked during the podcast. 'It's a big question.' Regardless of where the browser goes, Opera's pretty sure about the future of the internet itself. That's a huge shift, by the way. An agentic internet would be a massive and fundamental change from a user-driven internet to an agent-driven version. In a user-driven internet, you search, you see results, you make selections, you click links, you fill out forms, you book flights, and you buy products. In a sense, you are the agent. In an agentic internet, you tell something – maybe your agentic browser – to do those things for you. Except you don't say search, look, select, and buy; you say buy me more of the underwear I got six months ago. The agent then consults its memory, forms a plan, takes multiple steps, and handles it all: from which underwear you bought, and where you bought them, to finding the same ones online (and maybe checking around for better prices), to adding them to cart, to checking out … and reporting back to you with the results. The agent – in this case potentially an agentic browser – is therefore essentially a personal assistant, a force multiplier. But will an agentic browser be the main way we engage with agents? Perplexity seems to think it's pretty important, given the company's persistent and repeated but so far unfruitful attempt to buy a browser. Opera certainly thinks so, if only because Opera has a browser, and a very innovative one at that. Opera launched AI in a browser back in 2023 in a project called ARIA. ARIA enabled contextual interactions within web pages in a GPT-based chat interface. Over time, that's evolved to a tripartite strategy under the Opera Neon brand: The reality is that for many of us, most of our work happens in a browser. I'm writing this story in a browser. I recorded the interview in a browser. I've researched Opera and Perplexity in a browser. I made episode art for the podcast in a browser (thanks, Canva). Opera's thesis is that having agents embedded where you work makes them vastly more useful: they have access to your history, to your work, to your sites and apps. Important note: the Neon agentic browser's AI lives locally on your hardware, making it your agent, not Opera's, and not your employer's. This should boost your privacy, which is critical if you're going to give an agent access to very personal information including, likely, your credit card. Of course, this is just one vision of the future. Apple with Siri, as justly maligned as it is, would have another vision. Google, with Gemini and its own vast fleet of Android-enabled phones, would have another. Microsoft's Copilot is another. And OpenAI, which has ChatGPT apps for mobile devices as well as full computers, might have yet another vision of how we'll integrate AI into our lives and work. So whether the browser will be the locus of our agentic AI future or not is yet to be determined. Remember the old proverb: every problem looks like a nail to the person who only has a hammer. But it seems like a fairly good bet to me.

Technology meets hospitality at high tech coffee kiosk in downtown Denver
Technology meets hospitality at high tech coffee kiosk in downtown Denver

CBS News

time12 minutes ago

  • CBS News

Technology meets hospitality at high tech coffee kiosk in downtown Denver

Denver's 16th Street is nearing the finish line on its $175.4 million revitalization project, and new businesses are quickly filling in. Among them is Javai Coffee, a tech-forward coffee shop that's offering more than just a fresh cup of Joe. Located at 16th Street and Wazee Street, Javai operates a 24/7 automated robotic coffee kiosk, serving up espresso drinks in less than 60 seconds. Co-owner Grant Ross says the $22,000 machine is designed to be both efficient and inclusive, giving downtown workers, tourists, and late-night crowds access to affordable coffee at any hour. But Ross emphasizes that the model isn't about replacing jobs. Instead, Javai hires local service technicians to maintain the machine, stocking it with fresh milk and beans sourced from Colorado vendors. "We're not taking barista jobs, we're creating opportunities," Ross explained. "We want everything about this to be Colorado, from the ingredients to the people keeping it running." As 16th Street re-establishes itself as a hub for business and entrepreneurship, Ross believes Javai can play a role in that growth. "This is where we're starting. We want to own 16th Street so people can have affordable, quality coffee," he said. For a corridor that has long been considered the backbone of downtown Denver, Javai Coffee represents both innovation and investment, a blend fueling the future of the city's economy one cup at a time.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store